CliniNote, founded in 2020 and headquartered in Poland, is revolutionizing the healthcare and pharmaceutical sectors by leveraging AI and NLP to unlock clinical data. Their platform, branded with the slogan "Unlocking the power of clinical data," empowers healthcare providers and the pharmaceutical industry by delivering real-time, high-quality data that enhances research, drug development, market access, and patient care.
The company's proprietary AI-Agents and CliniNote Assistant increase clinical note-taking efficiency while simultaneously capturing comprehensive data without disrupting existing workflows. This capability generates Real-World Data points crucial for #ClinicalTrials and other applications, offering a frictionless experience that enhances data quality.
Recently, CliniNote secured a Seed Round investment on 29 September 2023, backed by investors such as Sunfish Partners and notable individuals like Winicjusz Filipow, Pawel Mandok, and Kasia Pieniadz. The company's commitment to data-driven innovation makes it a compelling prospect for further investment as it pushes forward advancements in healthcare technology.